| 产品名称 | Peptides EP11088_1 | BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01) |
|---|---|
| 目录号 | EP11088_1 |
| 别名 | BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP11088_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP11088_1 | BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
品名：BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
货号：EP11088_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.
| Protein | Human Bcr-abl 210 kD fusion protein |
| Species | Human |
| Application | Flow Cytometry |
| Indication | Cancer |
